Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00912873 · ClinicalTrials.gov registry record · Phase 4
Optimizing Local Anesthetic Concentration for Continuous Lumbar Plexus Nerve Blocks
A Phase 4 study of Hip Pain and Hip Arthroplasty, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT00912873 is a Phase 4 study of Hip Pain and Hip Arthroplasty that has completed, run by University of California, San Diego. The registered enrollment target is 50 participants, below the 263-participant average among 3 other Hip Pain trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00912873, a Phase 4 study of Hip Pain and Hip Arthroplasty, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a research study to determine if the concentration of local anesthetic through a catheter next to the nerves that go to the hip that is undergoing surgery, affects muscle strength and sense of touch experienced after surgery. This study is looking at the varying concentrations of local anesthetic placed through the catheter.
Conditions Studied
Interventions
- DRUG 0.1% Ropivacaine
- DRUG 0.4% Ropivacaine
Study Locations (1)
California
- UCSD Medical Center - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2008-05 |
| Est. Completion | 2009-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00912873
The ClinicalTrials.gov registry entry for NCT00912873 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 263-participant average among 3 other Hip Pain trials with a reported enrollment target (81% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hip Pain appearing as the primary indexed condition, and to 2 interventions - of which 0.1% Ropivacaine is the first listed.
NCT00912873 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00912873 about?
NCT00912873 is a clinical study titled "Optimizing Local Anesthetic Concentration for Continuous Lumbar Plexus Nerve Blocks". This is a research study to determine if the concentration of local anesthetic through a catheter next to the nerves that go to the hip that is undergoing surgery, affects muscle strength and sense of touch experienced after surgery. This study is looking at the varying concentrations of local anest...
What is the current status of trial NCT00912873?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2008-05. Estimated completion is 2009-06.
What conditions does trial NCT00912873 study?
This clinical trial studies the following conditions: Hip Pain, Hip Arthroplasty.
What interventions are being tested in trial NCT00912873?
The interventions under investigation include: 0.1% Ropivacaine (DRUG), 0.4% Ropivacaine (DRUG).
Who is sponsoring clinical trial NCT00912873?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00912873 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hip Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.